دورية أكاديمية

PCV39 Cost-Effectiveness of Rivaroxaban in the Treatment of Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease in Spain

التفاصيل البيبلوغرافية
العنوان: PCV39 Cost-Effectiveness of Rivaroxaban in the Treatment of Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease in Spain
المؤلفون: Gonzalez-Juanatey, J.R., Gómez, J.J., Lozano, F.S., Valle, A., Bowrin, K., Briere, J.B., Llorac, A., Millier, A., de Miguel, C., Diana, N.
المصدر: In Value in Health December 2020 23 Supplement 2:S493-S494
قاعدة البيانات: ScienceDirect
الوصف
تدمد:10983015
DOI:10.1016/j.jval.2020.08.530